New heart valve could transform open heart surgery for millions of patients globally
Caption: An advanced prototype of the PoliValve. Credit: Professor Raimondo Ascione, University of Bristol

A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by scientists at the universities of Bristol and Cambridge. The team’s latest in-vitro results, published in Biomaterials Science, suggest that the PoliValve could last for up to 25 years.

More than 1.3 million patients with diseased heart valves need replacement therapy globally each year. There are two artificial valves currently available for this; both have limitations either in durability or in biocompatibility. Biological valves are made from fixed pig or cow tissue and have good biocompatibility, meaning patients do not need life-long blood thinning tablets. However, they only last ten to 15 years before failing. While mechanical valves have very good durability, they have poor biocompatibility and patients must take daily blood thinning drugs to prevent life threatening complications due to .

Professor Geoff Moggridge, Head of the Structured Materials Group at Cambridge’s Department of Chemical Engineering and Biotechnology and Professor Raimondo Ascione, NHS Adult Cardiac Surgeon and Head of the Translational Biomedical Research Centre (TBRC) at the University of Bristol have spent three years conducting developmental work and extra-vivo and in-vivo testing on the new PoliValve.

The PoliValve, created by Professor Moggridge, Dr Marta Serrani and Dr Joanna Stasiak at Cambridge and Professor Ascione in Bristol, and building on earlier work with Professor Costantino’s group, is made from a special co-polymer and is designed to resemble the flexibility, biocompatibility and durability of a natural heart valve.

The device combines excellent durability with biocompatibility, addressing the limitations of current biological and mechanical artificial valves. It is made through a simple moulding process; hence it also reduces markedly manufacture and quality control costs.

Professor Moggridge, said: “These impressive results show the PoliValve is a promising alternative for valve replacement surgery. While further testing is needed, we think it could make a major difference to the hundreds of thousands of patients who get valve replacement surgery every year.”

Initial testing in animal has been undertaken at Bristol’s TBRC facility as a first mandatory in-vivo testing step to ensure safety. Long-term in-vivo testing is already planned and funded as a necessary additional step before bringing this new treatment to patients.

Professor Sir Nilesh Samani, Medical Director at the British Heart Foundation, said: “Patients requiring an artificial heart valve are often faced with the dilemma of choosing between a metallic or tissue valve replacement.

“A metallic valve is long lasting but requires the patient to take lifelong blood thinning drugs. Although this medication prevents clots forming on the valve, it also increases the risk of serious bleeding.

“Patients who have a tissue valve replacement usually don’t need to take this medication. However, the valve is less durable and means the patient may face further surgery.

“The polymer valve combines the benefits of both – it is durable and would not require the need for blood thinning drugs. While further testing is needed before this valve can be used in patients, this is a promising development, and the BHF is pleased to have supported this research.”

According to the ISO standards a new artificial heart valve must withstand a minimum of 200 million repetitions of opening and closing during bench testing (equivalent to five-year of ) to be tested in humans. The new Cambridge-Bristol polymeric valve has comfortably surpassed this.

The PoliValve has also exceeded the requirements of ISO standards for hydrodynamic testing, showing a functional performance in-vitro comparable to the best-in-class biological valve currently available on the market. The small feasibility pilot study in-vivo in three sheep at one to 24 hours after surgery has demonstrated the valve is easy to stitch in, no mechanical failure, no trans-valvular regurgitation, low trans-valvular gradients, and good biocompatibility at histopathology.

Professor Ascione added: “The transformational PoliValve results from an advanced Bristol/Cambridge-based biomedical cross-fertilisation between experts in biomaterials, computational modelling, advanced preclinical development/testing and clinical academics understanding the patient needs. The new valve could help millions of people worldwide and we aim to in patients within the next five years.”


Study finds TAVR is safe treatment for patients with bicuspid valve disease


More information:
Joanna Stasiak et al. Design, Development, Testing at ISO standards and in-vivo feasibility study of a novel Polymeric Heart Valve Prosthesis, Biomaterials Science (2020). DOI: 10.1039/D0BM00412J

Citation:
New heart valve could transform open heart surgery for millions of patients globally (2020, June 29)
retrieved 29 June 2020
from https://medicalxpress.com/news/2020-06-heart-valve-surgery-millions-patients.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



(Visited 4 times, 1 visits today)

Related posts:

WHO urges aggressive virus measures as flare-ups spark new closures
US records 63,643 new virus cases in 24 hours
Bosnian Muslims mark 25th anniversary of Srebrenica massacre
Brazil surpasses 70,000 coronavirus deaths
Nano-radiomics unveils treatment effect on tumor microenvironment
Malian president urges calm in overnight address after protesters take state TV off air
Hong Kong opposition pushes ahead with primaries under shadow of security law
US bets on untested company to deliver COVID-19 vaccine
Trump commutes prison sentence of longtime friend Roger Stone
Serbia reports record daily virus death toll
Nearly half of US adults projected to be obese by 2030
Building surge ICU capacity during COVID-19
New research suggests failure to retrieve relevant details from memory may underlie face blindness
Study pinpoints brain cells that trigger sugar cravings and consumption
Cancer health disparities published in new volume
France virus death toll exceeds 30,000
Uzbekistan reimposes virus lockdown after new cases
The people tirelessly restoring Notre-Dame to its former glory
A Confederate flag spotted in the window of police barracks in Paris
Pandemic inspires framework for enhanced care in nursing homes
Mali protesters demand president's resignation over jihadist conflict, economy
They got a big ER bill because hospitals couldn't test for virus
Milde und schwere COVID-19-Erkrankung: Unterschiede der Immunreaktion gegen SARS-CoV-2
Instagram to block all content promoting LGBT ‘conversion therapy’
Serbia, Kosovo resume ‘very difficult’ talks on normalising ties
Coronavirus can still be brought under control: WHO
Kein erhöhtes Demenzrisiko durch Tiefe Hirnstimulation
Balloons bring internet to Kenya's rural Rift Valley
How do COVID-19 antibody tests differ from diagnostic tests?
Virtueller DIVI-Kongress als Novum für 6.000 Teilnehmer
Decades on, 'hidden children' forced into orphanages of colonial France remain traumatised
Macron revamps cabinet, France rules out new lockdown and Louvre reopens
Fat cell hormone boosts potential of stem cell therapy
Neue Studie von UKE-Forschenden: SARS-CoV-2 befällt auch das Herz
UK travellers hope to salvage holidays as government eases quarantine rules
WHO special envoy on Covid-19 'extremely worried' about rise in cases worldwide
Sutter Health’s Request to Delay $575 Million Settlement Is Denied
Florida's curve no longer flat amid new surge of virus cases
DGK für Engagement in der Corona-Krise ausgezeichnet
Turkish court paves way to reconverting Hagia Sophia museum into a mosque
Netherlands takes Russia to European court over 2014 downing of Flight MH17
Coronavirus Live Updates: U.S. Nears 60,000 New Daily Cases
Largest study of prostate cancer genomics in Black Americans IDs targets for therapies
Medienpreis Urologie für fundierte Berichterstattung im Zeitalter von Dr. Google
Teletherapy, Popular in the Pandemic, May Outlast It
Ozone disinfection could safely allow reuse of personal protective equipment
COVID-19-Pandemie: Mehr Fälle des Brocken-Heart-Syndroms
The many lives of Hagia Sophia, Istanbul’s ‘wonder of wonders’
Meet the Heroes Fighting on the Front Lines Against Covid-19
How COVID-19 lockdown has impacted people with arthritis
Intensivmedizin an der Universitätsmedizin Göttingen wird erweitert
PSG to face Italy's Atalanta in Champions League quarter-finals
Study reveals circuit mechanism underlying nociceptive information processing
Kurznotizen am Erbgut - Biermann Medizin
Hong Kong to shut all schools after virus cases spike
Umfrage: Videosprechstunden bekommen in Corona-Krise Schwung
Lebanon’s neo-liberal wheels sped to a dream future, but the past applies the brakes
China vows to hit US with 'reciprocal measures' after Xinjiang sanctions
Why India cases are rising to multiple peaks
Ein Datenschatz für die Ganganalyse
Researchers identify key role of immune cells in brain development
Merkel press office staffer 'worked for years for Egyptian intelligence'
France investigates report of bodies 'left to rot' at Paris research centre
New study supports remdesivir as COVID-19 treatment
Neues Proteomik-Verfahren: Detaillierter Einblick in die gestresste Zelle
US sees latest record surge in virus cases amid wrangling over lockdown measures
Air Pollution Takes a Global Toll on Heart Health
Indoor airborne spread of coronavirus possible
Australia locks down second city as global cases top 12 million
Serbia drops plans for reimposed lockdown after days of violent protests
WHO launches global pandemic response probe
French César awards announce changes in response to Polanski #MeToo brouhaha
Airborne coronavirus transmission raises new questions and worries
Forecasts predict worse EU recession since WWII
reducing your risk of kidney stones
Scientists discover protective Alzheimer's gene and develop rapid drug-testing platform
UK declines participating in EU Covid-19 vaccine scheme over concerns of delays
Technology Bridges the Gap to Better Sight
CT of COVID-19 versus CT of influenza virus pneumonia
Bolivia's President Anez tests positive for Covid-19
Dogs May Be Good for Children’s Psychological Development
New study outlines best practices for delivering care via telehealth
What’s the Best Exercise for You? Twins Can Provide an Answer
A memory game could help us understand brain injury
Übernahme von Rhön-Klinikum AG durch Asklepios abgeschlossen
Corsicans harness the #IWas movement to challenge a culture of silence
Drug Giants Create Fund to Bolster Struggling Antibiotic Start-Ups
Coronavirus fears kept many essential workers at home in April, study finds
Stationär behandelte Bronchiolitis: Feste Nachsorgetermine möglicherweise gar nicht notwendig
Facing ridicule, France changes title for its ‘minister for attractiveness’
The Coronavirus Can Float in Indoor Air, W.H.O. Concedes
Covid-19 drug buyout: US's EU representative denies 'America First' policy on Remdesivir
Virtuelle Hämatologie/Onkologie-Jahrestagung: „Mehr Wissenschaft – mehr Hoffnung“
Streamlining acute malnutrition treatment brings same recovery in children at lower cost
A Missed Warning About Silent Coronavirus Infections
COVID-19-Studie: Studie errechnet doppelten Nutzen bei überlasteten Intensivstationen
Body of Seoul’s mayor found after massive search
Living close to green space benefits gut bacteria of urban, formula-fed infants
Regeneron Scientists Raced To Find Antibodies To Fight Covid-19. Then The Coronavirus Found Them.
DKG: Finanzierung der ambulanten Krebsberatung weiterhin nicht gesichert

Leave a comment

Your email address will not be published. Required fields are marked *